14 pending office actions • 8 clients • 12 examiners • 10 art units • 0 of 14 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (21%) |
| §112 only | 3 (21%) |
| Double-patenting + other | 1 (7%) |
| Multi-statute (no §101) | 7 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILLIS, DOUGLAS M | 2 | 82.4% | +19.5% |
| VU, JAKE MINH | 2 | 40.6% | +27.4% |
| BAEK, BONG-SOOK | 1 | 41.7% | +69.8% |
| COLEMAN, BRENDA LIBBY | 1 | 74.7% | +15.5% |
| KIM, SEONG JONG | 1 | — | — |
| COPPINS, JANET L | 1 | 72.9% | +25.5% |
| REYNOLDS, FRED H | 1 | 33.1% | +39.0% |
| YOON, TAE H | 1 | 66.5% | +24.7% |
| BARSKY, JARED | 1 | 50.3% | +23.1% |
| POPA, ILEANA | 1 | 21.5% | +14.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18134495 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | WILLIS, DOUGLAS M | 42d |
| 18630270 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | WILLIS, DOUGLAS M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18219656 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | VU, JAKE MINH | 154d overdue |
| 17790697 | ALKYLATED NUCLEOSIDES, AND COMPOSITIONS AND METHODS THEREOF FOR NUCLEIC ACID DELIVERY | CHO, DAVID H | 19d overdue |
| 18519269 | Pharmaceutical Mixture Comprising Amorphous Pitolisant | KIM, SEONG JONG | 18d overdue |
| 18648420 | ISO-OSMOTIC AND NEAR ISO-OSMOTIC OXYGEN THERAPEUTIC FORMULATIONS AND METHODS THEREOF | BAEK, BONG-SOOK | 4d overdue |
| 17616166 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | VU, JAKE MINH | 16d |
| 18088544 | POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY | POPA, ILEANA | 28d |
| 17719015 | High-Density Flagellin-Displaying Virus-Like Particle As Vaccine Carrier | LOUNTOS, GEORGE THEMISTOCLIS | 30d |
| 18279931 | PHOTOCAGED CITRULLINE ANALOGS AND METHODS FOR SITE-SPECIFIC INCORPORATION OF CITRULLINE INTO PROTEINS | REYNOLDS, FRED H | 57d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18219656 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | VU, JAKE MINH | 154d overdue |
| 18648420 | ISO-OSMOTIC AND NEAR ISO-OSMOTIC OXYGEN THERAPEUTIC FORMULATIONS AND METHODS THEREOF | BAEK, BONG-SOOK | 4d overdue |
| 18233077 | PROTEIN-POLYMER NANOASSEMBLIES AND INTRACELLULAR PROTEIN DELIVERY | YOON, TAE H | 3d overdue |
| 18574248 | CRYSTALLINE POLYMORPHS OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR, AND COMPOSITIONS AND METHODS THEREOF | COLEMAN, BRENDA LIBBY | 2d overdue |
| 18202033 | COMPOSITIONS OF BERBERINE URSODEOXYCHOLATE AND METHODS THEREOF FOR TREATING PRIMARY SCLEROSING CHOLANGITIS | BARSKY, JARED | 15d |
| 17616166 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | VU, JAKE MINH | 16d |
| 18088544 | POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY | POPA, ILEANA | 28d |
| 18134495 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | WILLIS, DOUGLAS M | 42d |
| Art Unit | Apps |
|---|---|
| 1624 | 3 |
| 1628 | 2 |
| 1618 | 2 |
| 1611 | 1 |
| 1621 | 1 |
| 1658 | 1 |
| 1762 | 1 |
| 1633 | 1 |
| 1693 | 1 |
| 1652 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18648420 | ISO-OSMOTIC AND NEAR ISO-OSMOTIC OXYGEN THERAPEUTIC FORMULATIONS AND METHODS THEREOF | NuvOx Pharma LLC | BAEK, BONG-SOOK | 1611 | §103§112 | Non-Final OA | 4d overdue | Pending | Apr 28, 2024 |
| 18630270 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | Shenzhen Hightide Biopharmaceutical, Ltd. | WILLIS, DOUGLAS M | 1624 | §112DP | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18574248 | CRYSTALLINE POLYMORPHS OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR, AND COMPOSITIONS AND METHODS THEREOF | Crimson Biopharm Inc. | COLEMAN, BRENDA LIBBY | 1624 | §112Other | Non-Final OA | 2d overdue | Pending | Dec 26, 2023 |
| 18519269 | Pharmaceutical Mixture Comprising Amorphous Pitolisant | Alfred E. Tiefenbacher GmbH & Co. KG | KIM, SEONG JONG | 1621 | §102§103 | Non-Final OA | 18d overdue | Pending | Nov 27, 2023 |
| 18280548 | METAP-2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF | Canwell Biotech Limited | COPPINS, JANET L | 1628 | §112 | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18279931 | PHOTOCAGED CITRULLINE ANALOGS AND METHODS FOR SITE-SPECIFIC INCORPORATION OF CITRULLINE INTO PROTEINS | UNIVERSITY OF MASSACHUSETTS | REYNOLDS, FRED H | 1658 | §102§103 | Non-Final OA | 57d | Pending | Sep 01, 2023 |
| 18233077 | PROTEIN-POLYMER NANOASSEMBLIES AND INTRACELLULAR PROTEIN DELIVERY | UNIVERSITY OF MASSACHUSETTS | YOON, TAE H | 1762 | §103 | Final Rejection | 3d overdue | Pending | Aug 11, 2023 |
| 18219656 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | Microvascular Therapeutics, LLC | VU, JAKE MINH | 1618 | §102§103Other | Final Rejection | 154d overdue | Pending | Jul 08, 2023 |
| 18202033 | COMPOSITIONS OF BERBERINE URSODEOXYCHOLATE AND METHODS THEREOF FOR TREATING PRIMARY SCLEROSING CHOLANGITIS | Shenzhen Hightide Biopharmaceutical Ltd. | BARSKY, JARED | 1628 | §103Other | Final Rejection | 15d | Pending | May 25, 2023 |
| 18134495 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | Shenzhen Hightide Biopharmaceutical, Ltd. | WILLIS, DOUGLAS M | 1624 | §112 | Final Rejection | 42d | Pending | Apr 13, 2023 |
| 18088544 | POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY | UNIVERSITY OF MASSACHUSETTS | POPA, ILEANA | 1633 | §103Other | Final Rejection | 28d | Pending | Dec 24, 2022 |
| 17790697 | ALKYLATED NUCLEOSIDES, AND COMPOSITIONS AND METHODS THEREOF FOR NUCLEIC ACID DELIVERY | Microvascular Therapeutics, LLC | CHO, DAVID H | 1693 | §103§112 | Final Rejection | 19d overdue | Pending | Jul 01, 2022 |
| 17719015 | High-Density Flagellin-Displaying Virus-Like Particle As Vaccine Carrier | University of Rhode Island Board of Trustees | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §103§112 | Non-Final OA | 30d | Pending | Apr 12, 2022 |
| 17616166 | COMPOSITIONS AND METHODS OF DETECTING AND TREATING THROMBOSIS AND VASCULAR PLAQUES | Microvascular Therapeutics, LLC | VU, JAKE MINH | 1618 | §103§112 | Final Rejection | 16d | Pending | Dec 02, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial